AzTrials
AzTrials

CatheterizationNCT03296735

A Difference in Subclavian Vein Catheterization Between Supine and Lateral Tilt Position - Stage I

A study testing Ipsilateral tilt and Contralateral tilt in people with Catheterization and Posture, run by Seoul National University Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Central venous catheterization is widely used for various purposes during surgery. For central venous catheterization, subclavian vein is selected because of the relatively low risk of infection, long-term patency and low patient discomfort. Read more about this study

Who is it for?
Ages 20 to 79 years
Conditions the study is for
Catheterization, Posture
What is being tested?
Ipsilateral tilt and Contralateral tilt
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
17 participants
Where
No sites listed yet
Study dates
15 Oct 2017to 31 Jul 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 79 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • the patients who receive elective neurosurgical surgery and require central venous catheter

Who cannot join

  • the patients who have puncture site infection
  • the patients who have chemoport, pacemaker in right subclavian vein
  • the patients who had received right mastectomy or right pneumonectomy
  • other contraindications for subclavian venous catheterization (eg. mass, hematoma, vegetation, and anticoagulation)

Trial locations and contacts

No sites are listed yet.

Hyung-Chul Lee, MD contact

+82-10-2456-6336

lucid80@gmail.com

About this study

Official title: A Difference in the Cross-section Area of Subclavian Vein Between Supine and Lateral Tilt Position: Its Clinical Impact on Subclavian Venous Catheterization - Stage II

Central venous catheterization is widely used for various purposes during surgery. For central venous catheterization, subclavian vein is selected because of the relatively low risk of infection, long-term patency and low patient discomfort. The cross - sectional area of the subclavian vein is an important factor to increase success rate. Several studies have reported that the Trendelenburg position increases the cross-sectional area of the subclavian vein, and the lateral tilt position can change the cross-sectional area of the subclavian vein. However, the impact of lateral tilt position to the cross-sectional area of the subclavian vein is not clear. The ipsilateral position can increase the cross-sectional area of the subclavian vein, and the contralateral position can decrease the cross-sectional area by gravity.

In the first stage of this study, we compare the cross-sectional area of subclavian vein using ultrasonography in supine, ipsilateral, and contralateral tilt position.

Being tested
Ipsilateral tilt, Contralateral tilt

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ipsilateral tiltProcedure or surgery

    The operation table will be tilted 20 degrees right laterally.

  • Contralateral tiltProcedure or surgery

    The operation table will be tilted 20 degrees left laterally.

Study groups in NCT03296735
Study groupRoleWhat they receive
Ipsilateral tiltExperimentalMeasuring the cross-sectional area of right subclavian vein in the 20 degree left tilting posture.
Receives: Procedure: Ipsilateral tilt
SupineNo interventionMeasuring the cross-sectional area of right subclavian vein in supine position.
Contralateral tiltActive comparatorMeasuring the cross-sectional area of right subclavian vein in the 20 degree left tilting posture.
Receives: Procedure: Contralateral tilt

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The cross-sectional area of right subclavian vein

    The cross-sectional area of right subclavian vein

    Measured: 1 minutes after position change

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2017
  2. Study start15 Oct 2017 (estimated)
  3. Primary completion31 Jul 2019 (estimated)
  4. Study completion31 Jul 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
17 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03296735
Sponsor's protocol ID
2017-110-871-1
Status last verified
Oct 2017
First submitted
25 Sep 2017
Last updated
11 Oct 2017
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Yoon HK, Lee HC, Kang P, Lee JM, Park HP, Cho YJ. Effects of ipsilateral tilt position on the cross-sectional area of the subclavian vein and the clinical performance of subclavian vein catheterization: a prospective randomized trial. BMC Anesthesiol. 2020 Sep 5;20(1):226. doi: 10.1186/s12871-020-01144-1.

    PubMed 32891115
  • Jung DE, Lee HC, Yoon HK, Park HP. The effects of ipsilateral tilt position on right subclavian venous catheterization: study protocol for a prospective randomized trial. Trials. 2018 May 24;19(1):292. doi: 10.1186/s13063-018-2666-8.

    PubMed 29793550

Questions about this trial

What is this clinical trial studying?

A study testing Ipsilateral tilt and Contralateral tilt in people with Catheterization and Posture, run by Seoul National University Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Hyung-Chul Lee, MD (+82-10-2456-6336, lucid80@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The cross-sectional area of right subclavian vein (time frame: 1 minutes after position change). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03296735, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Oct 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in